DUBLIN, Nov. 16, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xv794p/global_companion) has announced the addition of the "Global Companion Diagnostics Partnering 2010-2015 : Deal trends, players, financials and forecasts" report to their offering.
The Global Companion Diagnostics Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
Global Companion Diagnostics Partnering 2010-2015 provides the reader with the following key benefits:
- In-depth understanding of companion diagnostics deal trends since 2010- Analysis of the structure of companion diagnostics agreements with numerous real life case studies- Comprehensive access to over 250 actual companion diagnostics deals entered into by the world's biopharma companies, together with real world clause examples- Full listing of companion diagnostics deals by company A-Z, deal value, phase of development, deal type, and therapy focus- Identify leading companion diagnostics deals by value since 2010- Identify the most active companion diagnostics dealmakers since 2010- Detailed access to actual companion diagnostics deals and contracts enter into by the leading fifty big pharma companies- Understand the key deal terms companies have agreed in previous deals- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in companion diagnostics dealmaking
Chapter 3 - Average financial deal terms for companion diagnostics partnering
Chapter 4 - Leading companion diagnostics deals
Chapter 5 - Companion diagnostics contracts dealmaking directory
Chapter 6 - Future trends and companies in companion diagnostics deal making
Chapter 7 - Companion diagnostics partnering resource center
For more information visit
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets